Economic burden of head and neck cancer: A literature review

European Journal of Health Economics

Volumn 5, Issue 1, 2004, Pages 70-80

  Lee, Jennifer M ^b   Turini, Marco ^b   Botteman, Marc F ^a   Stephens, Jennifer M ^a   Pashos, Chris L ^a  

^a ABT ASSOCIATES   (United States)

^b Pharmacia Corporation   (Italy)

Author keywords

Burden of disease; Cost of illness; Cost effectiveness; Cost identification study; Head and neck cancer

Indexed keywords

CANCER SCREENING; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEAD AND NECK CANCER; HUMAN; MEDICAL SPECIALIST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; UNITED STATES;

ABSENTEEISM; COSTS AND COST ANALYSIS; HEAD AND NECK NEOPLASMS; HEALTH SERVICES RESEARCH; HUMANS;

EID: 1542314366     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-003-0204-3     Document Type: Review

References (55)

1. Arnold DJ, Funk GF, Karnell LH, Chen AH, Hoffman HT, Ricks JM et al (2000) Laryngeal cancer cost analysis: association of case-mix and treatment characteristics with medical charges. Laryngoscope 110:1-7
2. Aviv JE, Sataloff RT, Cohen M, Spitzer J, Ma G, Bhayani R et al (2001) Cost-effectiveness of two types of dysphagia care in head and neck cancer: a preliminary report. Ear Nose Throat J 80:553-6:558
3. Bennett CL, Lane D, Stinson T, Glatzel M, Buntzel J (2001) Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany. Cancer Invest 19:107-113
4. Benninger MS, Enrique RR, Nichols RD (1993) Symptom-directed selective endoscopy and cost containment for evaluation of head and neck cancer. Head Neck 15:532-536
5. Bentkover SH, Grande DM, Soto H, Kozlicak BA, Guillaume D, Girouard S (2002) Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg 4:114-119
6. Blackwell KE, Azizzadeh B, Ayala C, Rawnsley JD (2002) Octogenarian free flap reconstruction: Complications and cost of therapy. Otolaryngol Head Neck Surg 126:301-306
7. Blair EA, Callender DL (1994) Head and neck cancer. The problem. Clin Plast Surg 21:1-7
8. Bongers V, Hobbelink MG, van Rijk PP, Hordijk GJ (2002) Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer. Cancer Biother Radiopharm 17:303-306
9. Bonomi A, Palmer C, Ajax M, Peeples P, Jackson S (1999) Cost of managing mucositis and xerostomia in head and neck cancer patients undergoing chemoradiotherapy (CRT) or radiation (RT). Value in Health 2:197
10. Brandenburg JH (2001) Laser cordotomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 110:312-318
11. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL et al (2001) Harrison's principles of internal medicine, 15th edn. McGraw-Hill: New York
12. Brown ML, Hodgson TA, Rice DP (1993) Economic impact of cancer in the United States. In: Schottenfeld D, Fraumeni J (eds). Cancer epidemiology and prevention. Oxford University Press: New York
13. Brown ML, Riley GF, Schussler N, Etzioni R (2002) Estimating healthcare costs related to cancer treatment from SEER-Medicare data. Med Care 40 [8 Suppl]:IV-17
14. Chen AY, Callender D, Mansyur C, Reyna KM, Limitone E, Goepfert H (2000) The impact of clinical pathways on the practice of head and neck oncologic surgery: the University of Texas M.D. Anderson Cancer Center Experience. Arch Otolaryngol Head Neck Surg 126:322-326
15. Chiesa F, Mauri S, Tradati N, Calabrese L, Giugliano G, Ansarin M et al (1999) Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol 35:590-596
16. Cohen J, Stock M, Andersen P, Everts E (1997) Critical pathways for head and neck surgery. Development and implementation. Arch Otolaryngol Head Neck Surg 123:11-14
17. Cohen J, Stock M, Chan B, Meininger M, Wax M, Andersen P et al (2000) Microvascular reconstruction and tracheotomy are significant determinants of resource utilization in head and neck surgery. Arch Otolaryngol Head Neck Surg 126:947-949
18. Coyle D, Drummond MF (1997) Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchus. Medical Research Council CHART Steering Committee. Clin Oncol (R Coll Radiol) 9:313-321
19. Cragle SP, Brandenburg JH (1993) Laser cordectomy or radiotherapy: cure rates, communication, and cost. Otolaryngol Head Neck Surg 108:648-654
20. Cronin K, Lee B, Wang D (2001) Cost of treatment for squamous cell carcinoma of the head and neck in the United States. Value Health 4:94
21. Dickinson KD, Myers TJ (1990) Cost savings in cancer care from the selection of effective versus ineffective initial chemotherapy. Prog Clin Biol Res 339:465-476
22. DiNardo LJ, Lin J, Karageorge LS, Powers CN (2000) Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope 110 (10 Pt 1):1773-1776
23. Ferlay J, Bray F, Pisani P, Parkin DM (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. IARC CancerBase no. 5. IARC: Lyon
24. Foote RL, Buskirk SJ, Grado GL, Bonner JA (1997) Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck 19:692-700
25. Funk GF, Hoffman HT, Karnell LH, Ricks JM, Zimmerman MB, Corbae DP et al (1998) Cost-identification analysis in oral cavity cancer management. Otolaryngol Head Neck Surg 118:211-220
26. Funk GF, Karnell LH, Whitehead S, Paulino A, Ricks J, Smith RB (2002) Free tissue transfer versus pedicled flap cost in head and neck cancer. Otolaryngol Head Neck Surg 127:205-212
27. Gendron KM, Lai SY, Weinstein GS, Chalian AA, Husbands JM, Wolf PF et al (2002) Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg 128:258-262
28. Gregoire V, Hamoir M, Rosier JF, Counoy H, Eeckhoudt L, Neymark N et al (1999) Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiother Oncol 53:1-13
29. Heinz TR, Cowper PA, Levin LS (1999) Microsurgery costs and outcome. Plast Reconstr Surg 104:89-96
30. Hollenbeak CS, Lowe VJ, Stack BC Jr (2001) The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck. Cancer 92:2341-2348
31. Husbands JM, Weber RS, Karpati RL, Weinstein GS, Chalian AA, Goldberg AN et al (1999) Clinical care pathways: decreasing resource utilization in head and neck surgical patients. Otolaryngol Head Neck Surg 121:755-759
32. Jacobson J, Lang K, Menzin J, Earle C (2002) The health economic cost of squamous cell cancer of the head and neck in the elderly. American Society of Clinical Oncology Annual Meeting 2002
33. Kroll SS, Evans GR, Goldberg D, Wang BG, Reece GP, Miller MJ et al (1997) A comparison of resource costs for head and neck reconstruction with free and pectoralis major flaps. Plast Reconstr Surg 99:1282-1286
34. Leon X, Quer M, Orus C, Lopez-Pousa A, Pericay C, Vega M (2000) How much does it cost to preserve a larynx? An economic study. Eur Arch Otorhinolaryngol 257:72-76
35. Lowry JC (1990) Maxillofacial surgery: the economic aspect. Br J Oral Maxillofac Surg 28:16-19
36. McCrory AL, Magnuson JS (2002) Free tissue transfer versus pedicled flap in head and neck reconstruction. Laryngoscope 112:2161-2165
37. Miller MJ, Swartz WM, Miller RH, Harvey JM (1991) Cost analysis of microsurgical reconstruction in the head and neck. J Surg Oncol 46:230-234
38. Myers EN, Wagner RL, Johnson JT (1994) Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol 103:28-30
39. Owen JB, Grigsby PW, Caldwell TM, Konski AA, Johnson DJ, Demas WF et al (2001) Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04. Int J Radiat Oncol Biol Phys 49:633-639
40. Peterman A, Cella D, Glandon G, Dobrez D, Yount S (2001) Mucositis in head and neck cancer: economic and quality-of-life outcomes. J Natl Cancer Inst Monogr 29:45-51
41. Petruzzelli GJ, Brockenbrough JM, Vandevender D, Creech SD (2002) The influence of reconstructive modality on cost of care in head and neck oncologic surgery. Arch Otolaryngol Head Neck Surg 128:1377-1380
42. Poulsen M, Denham J, Spry N, Lamb D, Peters L, Krawitz H et al (1999) Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study. Australas Radiol 43:487-494
43. Ruff LK, Volmer T, Nowak D, Meyer A (2000) The economic impact of smoking in Germany. Eur Respir J 16:385-390
44. Sagar SM, McKenna G, Nolan MC (1994) A clinical audit of glottic cancer in Nova Scotia: a paradigm for effectiveness research. Clin Oncol (R Coll Radiol) 6:14-23
45. Schuller DE, Bier-Laning CM, Sharma PK, Siegle RJ, Pellegrini AE, Karanfilov B et al (1998) Tissue-conserving surgery for prognosis, treatment, and function preservation. Laryngoscope 108:1599-1604
46. Sculpher MJ, Sargeant IR, Loizou LA, Thorpe SM, Spencer GM, Bown SG (1995) A cost analysis of Nd:YAG laser ablation versus endoscopic intubation for the palliation of malignant dysphagia. Eur J Cancer 31A:1640-1646
47. Sturgis EM, Gianoli GJ, Miller RH, Fisher JW (2000) Avoiding transfusion in head and neck surgery: feasibility study of erythropoietin. Laryngoscope 110:S1-S7
48. Tan L, Greener CC, Seikaly H, Rassekh CH, Calhoun KH (1999) Role of screening chest computed tomography in patients with advanced head and neck cancer. Otolaryngol Head Neck Surg 120:689-692
49. Thoma A, Veltri K, Archibald S, Jackson S, Young JE (1999) Microsurgical reconstruction of the through-and-through defect in head and neck cancer: is it worth it? J Reconstr Microsurg 15:401-408
50. Tsue TT, Desyatnikova SS, Deleyiannis FW, Futran ND, Stack BC Jr, Weymuller EA Jr et al (1997) Comparison of cost and function in reconstruction of the posterior oral cavity and oropharynx. Free vs pedicled soft tissue transfer. Arch Otolaryngol Head Neck Surg 123:731-737
51. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK (1996) Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23:737-743
52. Van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, Snow GB et al (2001) The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer 37:2204-2211
53. Virgo KS, Paniello RC, Johnson FE (1998) Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124:564-572
54. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Head and neck cancer. N Engl J Med 328:184-194
55. Zavras A, Andreopoulos N, Katsikeris N, Zavras D, Cartsos V, Vamvakidis A (2002) Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health 19:12